ONCOPEPTIDES AB revenue breakdown overview

ONCOPEPTIDES AB revenue for the last year amounted to 3.61 M USD, the most of which — 3.48 M USD — came from its highest performing source at the moment, Pharmaceutical Drugs, the year earlier bringing 797.90 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought ONCOPEPTIDES AB 2.40 M USD, and the year before that — 744.42 k USD.